| Sign In to gain access to subscriptions and/or personal tools. |
Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary CareDepartments of Cardiology, Children's Hospital Boston, sarah.deferranti{at}cardio.chboston.org
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts
Department of Medicine, Children's Hospital Boston
Division of Hematology, Children's Hospital Boston
Laboratory Medicine, Children's Hospital Boston
Division of General Pediatrics, Department of Pediatrics, Children's Hospital at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire This prospective study assessed the clinical application of a nonfasting low-density lipoprotein cholesterol measure in a pediatric primary care population. A homogenous direct low-density lipoprotein cholesterol assay was tested in healthy children, aged 4 to 12 years, at risk for hyperlipidemia, as defined by American Academy of Pediatrics, and including patients with incomplete family histories. This nonfasting homogeneous assay was comparable to modified ß quantification, the gold standard reference method of measuring low-density lipoprotein cholesterol, and the current recommended screening method, total cholesterol. Results from the study suggest that this nonfasting assay can provide more direct low-density lipoprotein cholesterol measurements for healthy children, with improved clinical utility and greater overall patient convenience in testing for important cholesterol abnormalities.
Key Words: hypercholesterolemia low-density lipoprotein homogenous direct assay child screening
Clinical Pediatrics, Vol. 46, No. 5,
441-445 (2007) This article has been cited by other articles:
|
|
||||||||||||||


